Skip to content

GYNAN

Active
Private limited companyfounded 20188 yrs activeGrand-Rue(L) 18, 7900 Leuze-en-Hainaut, BelgiumKBO/BCE: BE 0704.772.009

GYNAN has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €19k and a net result of €278k. Equity is growing by ~18.8% per year across the filed fiscal years. Its solvency ranks better than 11% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
72 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency31▼-69
Growth58▼-20
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days acceptable
Liquidity tight (current ratio 1.04; short-term debt: 93.7% and cash: 63.7% of total assets), and 94.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Nine signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
5.8%
Return on assets
86.6%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 8 years 0 10 y
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 11% of 16491 sector peers (2025).
NBB · sector comparison
Position among 16491 sector peers
Solvency
better than 11%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
4 d early
2024
on the day
2023
on the day
2022
3 d early
2021
8 d early
2020
4 d early
2019
118 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€19k▼ 95.9%
2024 · €451k
2019: €121k 2020: €139k 2021: €223k 2022: €388k 2023: €289k 2024: €451k
2019 → 2025
Total assets
€321k▼ 29.4%
2024 · €455k
2019: €147k 2020: €195k 2021: €242k 2022: €393k 2023: €476k 2024: €455k
2019 → 2025
Net result
€278k▼ 35.7%
2024 · €433k
2019: €103k 2020: €118k 2021: €84k 2022: €195k 2023: €268k 2024: €433k
2019 → 2025
Working capital
€11k▼ 97.4%
2024 · €440k
2019: €104k 2020: €114k 2021: €201k 2022: €355k 2023: €271k 2024: €440k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€223k-€388k▲ 73.7%€289k▼ 25.5%€451k▲ 56.3%€19k▼ 95.9%
Operating result€112k-€292k▲ 160%€361k▲ 23.8%€577k▲ 59.6%€415k▼ 28.1%
Net result€84k-€195k▲ 131%€268k▲ 38.0%€433k▲ 61.3%€278k▼ 35.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€200k€400k€600kOperating result 2021: €112k€112kNet result 2021: €84k€84kOperating result 2022: €292k€292kNet result 2022: €195k€195kOperating result 2023: €361k€361kNet result 2023: €268k€268kOperating result 2024: €577k€577kNet result 2024: €433k€433kOperating result 2025: €415k€415kNet result 2025: €278k€278k20212022202320242025
The operating result falls in 2025; 2025 is 28% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €321k
Fixed assets €9k▼ 30.1%
Current assets €313k▼ 29.4%
Equity and liabilities €321k
Equity €19k▼ 95.9%
Debt €303k▲ 7,679%
The debt ratio rises from 0.9% to 94.2%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€421k
2024 · €583k
Cash flow
€285k
2024 · €439k
Solvency
5.8%
2024 · 99.1%
Current ratio
1.04
Quick ratio
1.04
Debt / equity
16.28
2024 · 0.01
ROA
86.6%
2024 · 95.1%
Interest coverage
8.89
2024 · 287.79
Debt
€303k
2024 · €4k
Debt ≤ 1 year
€301k
2024 · €2k
Income taxes
€89k
2024 · €142k
A ratio outside any meaningful range has been withheld (balance sheet total €321k, equity €19k).
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€455k€321k
Fixed assets21/28€13k€9k
Tangible fixed assets22/27€13k€9k
Furniture and vehicles24€13k€9k
Current assets29/58€443k€313k
Amounts receivable within one year40/41€23k€11k
Other amounts receivable41€23k€11k
Cash at bank and in hand54/58€260k€205k
Deferred charges and accrued income490/1€160k€97k
Equity and liabilities
Total equity and liabilities10/49€455k€321k
Equity10/15€451k€19k
Contributions10/11€19k€19k=
Profit (loss) carried forward14€433k-
Amounts payable17/49€4k€303k
Amounts payable within one year42/48€2k€301k
Trade debts44€2k€8k
Suppliers440/4€2k€8k
Taxes, remuneration and social security45-€42k
Taxes450/3-€42k
Other amounts payable47/48-€252k
Accrued charges and deferred income492/3€2k€2k=
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€7k
Other operating charges640/8€164€74
Gross operating margin9900€583k€422k
Operating profit (loss)9901€577k€415k
Financial charges65/66B€2k€47k
Recurring financial charges65€2k€47k
Profit (loss) for the period before taxes9903€575k€367k
Income taxes67/77€142k€89k
Profit (loss) for the period9904€433k€278k
Profit (loss) for the period to be appropriated9905€433k€278k
Appropriation of the result
Profit (loss) to be appropriated9906€703k€711k
Profit (loss) brought forward from the previous period14P€270k€433k
Profit to be distributed694/7€270k€711k
Return on contributions (dividend)694€270k€711k

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
27-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2019net €433k ▲61.3%
Operating result €577k, net result €433k, both a record.
31-12
Financial Liquidity times 76current ratio 186.29
Current ratio from 2.46 to 186.29; short-term debt falls from €186k to €2k.
31-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
28-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Liquidity times 7current ratio 85.88
Current ratio from 12.26 to 85.88; short-term debt falls from €18k to €4k.
23-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Weakest financial yearnet €84k ▼28.8%
Net result drops to €84k, the lowest in the series; recovery starts the following year.
31-12
Financial Liquidity quadruplescurrent ratio 12.26
Current ratio from 3.05 to 12.26; short-term debt falls from €56k to €18k.
31-12
Financial Equity above €200kEq €223k ▲60.7%
3 profitable years in a row build equity to €223k.
27-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
26-11
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 118 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Leuze-en-Hainaut · 2 establishment units since 2018
establishment All 2 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Grand-Rue(L) 187900 Leuze-en-Hainaut
Ground area
2,950 m²
Building footprint
499 m²
Volume, LiDAR
3,355 m³
3 parcels, Flanders, Wallonia · tallest building 10.8 m, ±3 floors. Linked by address, not a title deed.
2 establishment units
Rue de la Bergerie 61D, 7080 Frameries
Specialist medical practice
since 20182.279.676.380
Witloofstraat 1B, 3070 Kortenberg
Specialist medical practice
since 20182.279.676.479
3 parcels
Flanders 1 (33.3%) Wallonia 2 (66.7%)
Parcel (capakey) Region Area Buildings Height / fl.
53045A0093/00R000 Wallonia 1,904 m² 1 · 259 m² 7.1 m · 2 fl.
24055A0004/00L000 Flanders 584 m² 1 · 104 m² 9.6 m · 2 fl.
57048D0657/00M000 Wallonia 462 m² 1 · 136 m² 10.8 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 2
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

254900457RT7QPH3YZ42
no longer live in the LEI register

Similar companies · same sector, comparable size

Of 16,627 companies in sector 86220 we hold annual accounts for 7,973. 3,053 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded19-09-2018
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86109Human health activities
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.